about
Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED.The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical dataNon-linear mixed effects modelling of positron emission tomography data for simultaneous estimation of radioligand kinetics and occupancy in healthy volunteers.Population pharmacokinetics of ethambutol in South African tuberculosis patients.Population pharmacokinetics of edoxaban in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism--the Hokusai-VTE phase 3 studyEdoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism.A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A.Role of modelling and simulation: a European regulatory perspective.Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog Alfa.Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.A diagnostic tool for population models using non-compartmental analysis: The ncappc package for R.Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical Trial.Population pharmacokinetics of plasma-derived factor IX: procedures for dose individualization.Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.A rational approach for selection of optimal covariate-based dosing strategies.Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years: a population analysis based on 50 patients with long-term prophylactic treatment for haemophilia A.Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment study.Kinetic Observations in Neonatal Mice Exposed to Lead via MilkToxicokinetics of Lead in Lactating and Nonlactating MiceReduced and optimized trial designs for drugs described by a target mediated drug disposition model.Kinetics of methylmercury and inorganic mercury in lactating and nonlactating miceReal life experiences of a PK dosing study-Challenges and lessons learnedPharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis TrialsHandling interoccasion variability in model-based dose individualization using therapeutic drug monitoring dataModel-based evaluation of low-dose factor VIII prophylaxis in haemophilia A
P50
Q30977125-EDFEF465-5487-4A75-A9C8-FECF16CE7579Q33212737-8CEF1724-8600-4CCB-B722-81CF010EFD33Q34198755-B27781BF-2830-4BC6-9055-B4CFA5E1C904Q35191463-81D674AE-ACEB-4867-9EBD-736384399F90Q36410089-70F449ED-B2D3-436C-978E-818E5AC32308Q36840816-97964A0C-33B5-4A99-AB6C-82D0374C7E00Q37219058-E29DE484-AF31-491C-A2E0-0ED90F180E66Q37976876-9B1E0726-9F93-42B3-8A23-F8B9FD24A0F2Q38822601-ADB155D0-E745-4034-8078-EBEFD0C9838CQ39062032-6E91877A-B59F-4A55-A3F5-75205F3119A4Q39901037-06EC9E1B-E6CE-46DC-A9A2-B7743DD9BF61Q39941768-0D2B1FF4-9294-4E08-96B4-2F94EBFD1E6EQ40066317-67FB6D17-5B30-4134-8864-6149F693510DQ42283823-4E14DF67-0085-4E75-94DC-9A611CDAAE89Q44289515-19819101-84E3-4421-9BD4-78C4FB33D782Q45886381-FADF3E4F-F6FC-4752-9CFC-37176BBC0B1BQ53509243-4A74362C-1DFE-4CCB-93F6-E333FC2A101CQ59259175-13AA56F0-7FB1-485C-B153-3DBFFBACCC10Q59259178-EEA81084-FCB9-44B5-89DA-5677842050C6Q64905108-BA6A61D3-34E8-4FFD-A208-CAEA37574F1BQ77103624-5C7337CC-AEF7-4F9D-AA4C-22225ECA3800Q88296075-EFCCF88B-CAFB-42B3-8F08-64125CB2AAFAQ88628130-657D8BE8-C5A5-4C62-A5EC-C2CAF1A04045Q91607781-8164D7E3-138D-4069-8192-C1CAD46BBF77Q91723993-3B29A283-51EB-4382-91D8-8AA35E22C28A
P50
description
researcher
@en
wetenschapper
@nl
name
Jönsson S
@nl
Siv Jönsson
@en
type
label
Jönsson S
@nl
Siv Jönsson
@en
altLabel
Jönsson S
@en
prefLabel
Jönsson S
@nl
Siv Jönsson
@en
P106
P31
P496
0000-0001-8240-0865